Bellerophon Therapeutics Inc (BLPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2013 | 12-2012 | |
| Cash Flows From Operating Activities | ||
| Net Income | -45,223 | -46,220 |
| Depreciation Amortization | 597 | 80 |
| Other Working Capital | -1,700 | 5,310 |
| Other Operating Activity | 1,612 | 4,610 |
| Operating Cash Flow | $-44,714 | $-36,220 |
| Cash Flows From Investing Activities | ||
| PPE Investments | -1,077 | -3,470 |
| Investing Cash Flow | $-1,077 | $-3,470 |
| Cash Flows From Financing Activities | ||
| Other Financing Activity | 45,791 | 39,700 |
| Financing Cash Flow | $45,791 | $39,700 |
| Net Cash Flow | $N/A | $0 |
| Free Cash Flow | ||
| Operating Cash Flow | -44,714 | -36,220 |
| Capital Expenditure | -1,077 | N/A |
| Free Cash Flow | -45,791 | -36,220 |